Evogene (EVGN) Cost of Revenue (2016 - 2025)
Historic Cost of Revenue for Evogene (EVGN) over the last 14 years, with Q3 2025 value amounting to $157000.0.
- Evogene's Cost of Revenue fell 8493.28% to $157000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year increase of 2761.27%. This contributed to the annual value of $2.4 million for FY2024, which is 4066.19% up from last year.
- As of Q3 2025, Evogene's Cost of Revenue stood at $157000.0, which was down 8493.28% from $136000.0 recorded in Q2 2025.
- Evogene's 5-year Cost of Revenue high stood at $1.6 million for Q1 2025, and its period low was $101000.0 during Q3 2021.
- In the last 5 years, Evogene's Cost of Revenue had a median value of $310000.0 in 2024 and averaged $406210.5.
- In the last 5 years, Evogene's Cost of Revenue soared by 59487.18% in 2021 and then crashed by 8493.28% in 2025.
- Over the past 5 years, Evogene's Cost of Revenue (Quarter) stood at $267000.0 in 2021, then skyrocketed by 36.33% to $364000.0 in 2022, then grew by 9.34% to $398000.0 in 2023, then surged by 89.7% to $755000.0 in 2024, then crashed by 79.21% to $157000.0 in 2025.
- Its last three reported values are $157000.0 in Q3 2025, $136000.0 for Q2 2025, and $1.6 million during Q1 2025.